Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
SBTX

SBTX - Silverback Therapeutics, Inc. Stock Price, Fair Value and News

$16.75-0.75 (-4.29%)
Delayed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

SBTX Price Action

Last 7 days

-10.7%

Last 30 days

25.2%

Last 90 days

13.4%

Trailing 12 Months

229.1%

SBTX RSI Chart

SBTX Valuation

Market Cap

1.6B

Price/Earnings (Trailing)

-33.15

Price/Sales (Trailing)

45.4K

Price/Free Cashflow

-35.36

SBTX Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

SBTX Fundamentals

SBTX Revenue

Revenue (TTM)

30.0K

Rev. Growth (Yr)

41.3K%

Rev. Growth (Qtr)

313.6%

SBTX Earnings

Earnings (TTM)

-49.1M

Earnings Growth (Yr)

-28.67%

Earnings Growth (Qtr)

-52.83%

SBTX Profitability

Return on Equity

-24.43%

Return on Assets

-22.57%

Free Cashflow Yield

-2.83%

SBTX Investor Care

Shares Dilution (1Y)

1.24%

Diluted EPS (TTM)

-0.51

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20240000
2023994.5K673.0K351.5K30.0K
20224.5M3.4M2.4M1.3M
20210005.5M
Get all data in R, Python etc through our Historical Stock Data APIs

About Silverback Therapeutics, Inc.

SBTX
0
 WEBSITEsilverbacktx.com

Silverback Therapeutics, Inc. Frequently Asked Questions

What is the ticker symbol for Silverback Therapeutics, Inc.? What does SBTX stand for in stocks?

SBTX is the stock ticker symbol of Silverback Therapeutics, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Silverback Therapeutics, Inc. (SBTX)?

As of Fri Dec 20 2024, market cap of Silverback Therapeutics, Inc. is 1.63 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SBTX stock?

You can check SBTX's fair value in chart for subscribers.

Is Silverback Therapeutics, Inc. a good stock to buy?

The fair value guage provides a quick view whether SBTX is over valued or under valued. Whether Silverback Therapeutics, Inc. is cheap or expensive depends on the assumptions which impact Silverback Therapeutics, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SBTX.

What is Silverback Therapeutics, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, SBTX's PE ratio (Price to Earnings) is -33.15 and Price to Sales (PS) ratio is 45.42 Thousand. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SBTX PE ratio will change depending on the future growth rate expectations of investors.